Schecter Alison D, Berman Adriane B, Yi Lin, Ma Harry, Daly Christine M, Soejima Kenzo, Rollins Barrett J, Charo Israel F, Taubman Mark B
The Cardiovascular Institute, Department of Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.
J Leukoc Biol. 2004 Jun;75(6):1079-85. doi: 10.1189/jlb.0903421. Epub 2004 Mar 12.
Monocyte chemoattractant protein-1 (MCP-1, CCL2) is a mediator of inflammation that has been implicated in the pathogenesis of a wide variety of human diseases. CCR2, a heterotrimeric G-coupled receptor, is the only known receptor that functions at physiologic concentrations of MCP-1. Despite the importance of CCR2 in mediating MCP-1 responses, several recent studies have suggested that there may be another functional MCP-1 receptor. Using arterial smooth muscle cells (SMC) from CCR2(-/-) mice, we demonstrate that MCP-1 induces tissue-factor activity at physiologic concentrations. The induction of tissue factor by MCP-1 is blocked by pertussis toxin and 1,2-bis(O-aminophenyl-ethane-ethan)-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, suggesting that signal transduction through the alternative receptor is G(alphai)-coupled and dependent on mobilization of intracellular Ca(2+). MCP-1 induces a time- and concentration-dependent phosphorylation of the mitogen-activated protein kinases p42/44. The induction of tissue factor activity by MCP-1 is blocked by PD98059, an inhibitor of p42/44 activation, but not by SB203580, a selective p38 inhibitor. These data establish that SMC possess an alternative MCP-1 receptor that signals at concentrations of MCP-1 that are similar to those that activate CCR2. This alternative receptor may be important in mediating some of the effects of MCP-1 in atherosclerotic arteries and in other inflammatory processes.
单核细胞趋化蛋白-1(MCP-1,CCL2)是一种炎症介质,与多种人类疾病的发病机制有关。CCR2是一种异源三聚体G偶联受体,是已知的唯一在生理浓度的MCP-1下起作用的受体。尽管CCR2在介导MCP-1反应中很重要,但最近的几项研究表明可能存在另一种功能性MCP-1。利用CCR2基因敲除小鼠的动脉平滑肌细胞(SMC),我们证明MCP-1在生理浓度下可诱导组织因子活性。百日咳毒素和1,2-双(O-氨苯基乙烷)-N,N,N',N'-四乙酸乙酰甲酯可阻断MCP-1对组织因子的诱导,这表明通过替代受体的信号转导是G(αi)偶联的,并且依赖于细胞内Ca(2+)的动员。MCP-1可诱导丝裂原活化蛋白激酶p42/44的时间和浓度依赖性磷酸化。p42/44激活抑制剂PD98059可阻断MCP-1对组织因子活性的诱导,但选择性p38抑制剂SB203580则不能。这些数据表明,SMC具有一种替代的MCP-1受体,该受体在与激活CCR2相似的MCP-1浓度下起信号作用。这种替代受体可能在介导MCP-1在动脉粥样硬化动脉和其他炎症过程中的某些作用方面很重要。